 Welcome back on this Tuesday. Norman, good to see you all. Grant, good to see you all. Everybody, everybody on YouTube, Facebook. Welcome back. Good to see you, Lita. Good morning. Looks like we're having a little bit of fun morning again. Yesterday was actually a pretty good day, shockingly. We had a really nice good rally in the Dow. We had a nice little market, all-time highs. A lot of the stocks and swing trades that we did pretty well. And also, we're getting a really, really, really good pre-market this morning. Once again, if some of you on YouTube, Facebook, if you missed it, you can always do a trial. Just jump in there and join us. But we're getting a really nice run on KNDI. I mean, this thing just ran at 845. We had two nice runners. We had the RELI, which we're going to talk about next. And then, well, we're going to go over the stocks we traded yesterday and the KNDI. But this thing is just a really, really nice stock. I'm seeing a lot of orders right now that are hovering on the offer right now. We see those guys get and take out, then we'll see it. You also go see, back in December, we are testing a major resistance. But really, really nice move. I mean, the thing just ran for a nice little 30 cents. Nice little level two stock. I think everybody can afford it. But let's go over a couple of things really quick and talk about what's going on. I mean, a doubt was, obviously, you could see. And the S&P have done really, really well, almost at the all-time highs of the market, right around there. Omicron, the virus is really not as serious as it seems for some people. They look at it. The CDC lowered it down to five days. So it's funny, though, you're hearing about Omicron, but you're not hearing about COVID-19. You're not hearing about Delta anymore, right? So is this going to be a virus that's going to be smaller? Is this going to be a bad one coming up? We don't know, but we all know that now they're starting to get these tests out a lot more. And I think everybody here got tested. I mean, if not, try to get tested. Here in New York, there's almost like a three-day waiting list just to get tested. And by that time, if you did have it, it's probably over. But anyway, I think the market does like that. And listen, there's no better safer place than be right here in the cybergroup room, just trade. So anyway, I'm looking really quick at the stock RELI. A lot of you remember we traded this couple of days ago. The stock went from $250 to almost about $8,000 a share. Stock is doing really, really well. There's also some warrants on the stock. We'll talk a little bit about that. Did it get up here? Yeah, there you go. There's the warrant on that stock. Obviously trading the commons a lot easier. Warrants, I know Josh did clash yesterday. And he was specifically taking a lot of time talking about the time and sales window. Time and sales is very, very critical because I'm a tape reader. We see a lot of these orders on level four. You all know what we're talking about here. We watch iceberg orders. We watch big block orders. And you know what? Sometimes those orders get executed. Sometimes they don't. How do we know that? Time and sales. So if you had missed that class, make sure you get in it. If you're not a student, talk to education advisor and tell you how to get involved. So anyway, let's talk about what happened yesterday. We had a couple of stocks. FTFT was one of them. And let me just bring up the two-day chart right here. So this stock obviously was a really, really nice, slow moving stock. A little too slow for my taste, but you could have traded a lot of shares of it. Stock started right around $1.10, finished up all the way to $1.80. And then obviously this massive sell just came in right around that, right over close to about $2.50 or something like that, yeah, right around there. $2.56, boom, the thing came crashing down. So you could see it. Then it started making lower, higher lows. And that's about it. Once that happens, it's game over. Embot is gone. This stock got destroyed yesterday, destroyed. You can't see it from here, but Embot had an, I'm sorry, not Embot. There was a BBIO we got to talk about. Embot was, it was BBIO. Sorry about that. We're going to talk about Embot really quick. So BBIO got crushed yesterday. This stock was from $40, went all the way down to a price around $11.50. And what was unbelievable about this stock is we know it's a pharmaceutical stock. And at $9.30, when we saw the stock making a low, you know, a lot of people think it's a dead cat bounce, it's stocking a bounce. Well, sure enough, it didn't. And you could see how the stock right at the open went from $12.80 all the way down to $11.40. Now she's up today, you know, and you got to work off yesterday's resistance levels to know where we're at, but just be very careful of the stock. You know, it got pretty nasty a few times with the spread in all. So don't go crazy thinking about the dead cat bounce on it. But it looks like she did build a lot of support levels right around here, around $11.50. So we had that one. Now on Embot was actually pretty decent yesterday. It was a fast runner. It just literally just popped. Had a nice little pre-market and you could see it, you know, had a little nasty shake right here, but Embot was one of those stocks that was like the Tita Tottering ones. It was playing games, playing games and boom, the thing just came right back down, which was a very ugly look. And then it went right back up. So you had to get lucky on the stock to get the right place at the right time. But, you know, you could see it just out of nowhere, you know, you had to beat the right place at the right time. If you hit any of these big spikes right here, you got pretty much got lucky, all right? And that's pretty much does it with that. So overall it wasn't the greatest day, but other than a few of those little odds and ends. And then we had a couple of the swing trades that did pretty well. I told you Apple did pretty well on Apple. You could see it testing all-time highs. These are more swing trades. So we do do some swing trades. Boyle also did pretty well yesterday. So Boyle, if it could get past this $30 resistance levels, Boyle can make a nice move from all the way from 100,000 all the stock I jumped into a swing trade. And we had, well, and also we have some of the Corona stocks, ABBV doing really, really well. You could see that stock over at 100, almost 134. This is the company that makes the test kits. Come on, read between the lines, everybody. You know, when there's a catastrophe, I hate to say it's an opportunity, OK? So when I hear anything about, you know, that could affect a major company. First thing I do is I go to the stock. And that's why people love trading, OK? You don't buy a stock because, oh, I love the company. You buy the stock. I mean, buying a stock because you love the company is one thing. But you could be buying a stock and love the company and go nowhere, OK? You're buying the company because of the volatility, because of the news, things that are out there that are driving the stock go up. And we all know that's the reason why this one and also Fiserv, and you probably should have learned that from Moderna, you know, going from $20 to $500, you know, being vaccine stocks. Now let's talk about what's moving today. Couple of nice stocks. Charlie made about, oh, Charlie did pretty well on that RELI, right? Look at that. Beautiful, way to go. Let me just share that in the, some people in the room can't see that in the cyber group room. But yeah, Charlie Z just bought that stock, RELI, but at 640 and sold at 747, way to go. Round of applause for him. So anyway, that stock right there, RELI had a really decent, had a little bit of a push yesterday, you could see it, had that little bit of a move too. That was another stock, but then she kind of held up, she's holding pretty strong right now. But be very careful because the stock we knew was a short squeeze. When we traded it back on this day right here, you could see it, we blow this up so you guys could see that. You saw it when we saw this little push-up gap up and then all of a sudden ran all the way up to here, ran from $5 to $820 and then boom, it came away back down to $4. Unbelievable short squeeze, stock had one nasty, ugly shake in it also. So be very, very careful on that. I'm gonna hop over here on the level four and show what we've got going on. So we got a couple of iceberg orders right here, you could see them right there, a nice big one showed $50,000, right around some $50. He pulled his order and that's when the stock ran and he came back, okay? And that's when the stock came back down. You can see another support level was right here, but listen, look at the heat map. Those orders are what we need to focus on. Those orders are what dictate the direction of the stock. If you wanna question them, no problem. Let me know how that works out for you. But listen, you're not trading 50,000 shares, someone else is. You gotta find, follow the algorithms, you gotta follow the high-frequency trades, you gotta follow the institutions. KNDI, let's go hop over there. So KNDI is starting to back off a little bit. I'm not really a big fan of it as of right now. You could see how that nice little pop, we had some decent volume, but volume started dying down right here on the bottom. You got some orders out there, 11,000, right here. So we're not seeing a huge amount of iceberg orders as much as we like, not as pretty as the RELI, where you see these. But you know what? Nice little pop early, we'll put it on the watch list. We'll see what happens when it opens up. Next one that made our list, APPS. Now this one's obviously a little bit more expensive. For some of you advanced traders, this might be up your RELI, the stock was a $100, $90 stock got destroyed, came to a major support levels around 50. The stock is pretty, it's pretty decent because you can see a little bit more big block orders, but they're not really that much of an order out there. Listen, you can see 200, 300, but then you got 4,000, 3,000. Listen, doesn't sound like a lot, but when everyone's showing 100 shares and those big block orders out there are 20, 30 times bigger, yeah, you know what, that is an iceberg order. So, but you can see we got this major resistance at 4220. So it's gotta break that before it goes any higher. And like I said, I'll put the PBIO on there just for hell of it, you know, stock got crushed, we'll see how it moves. Norman's calling out in the cyber group room, BVXV. You know, I had that stock on the watch list this morning, Norman, and then now looking at it, you could see it had a really nice run up this, in around four o'clock this morning, five o'clock, ran from like $2.75 all the way back down to three. So, listen, it could move in the morning, I put it on the B list, but it's definitely not, maybe even the C list, because I don't like to see stocks like that and we see it happen all the time when the market, in some previous morning meetings, and sometimes they don't go anywhere, but because it's got eight million shares, because it's got a nice little price levels and tier sizes, it's not the end of the world, all right? Okay guys, so that pretty much does it. We have our list, we know what this week entails. It's the slowest week of the year. Apparently it didn't seem that way yesterday with the Dow and everything else, but you know what, a lot of people ain't traveling, it's not like everyone, historically, we've been gone this week, so we are getting some good volatility, which is great, but the big thing is this, we wanna finish out the year as a positive. There's some of you students, you got those yearly journals that we gave you, you know what, you got the daily journals, the yearlies, it's always exciting to know how you finished out the end of the year, and that will let's get you set up for 2022, all right? Happy trading everyone, we'll start commentary in 15 minutes. If you're watching on YouTube, Facebook Live, we'll be back here at 2.30 every day, here at 9 a.m. and 2.30, or just always like us, friend us, watch some more videos, or join us and do a trial and see how it goes, all right? Good luck everyone, happy trading.